The U.S. Food and Drug Administration announced that Actavis Inc. has recalled 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches from wholesale and retail locations after one patch was found to have released it active ingredient faster than normal. Read more at http://www.fda.gov/Safety/Recalls/ucm230498.htm.